Your browser is no longer supported. Please, upgrade your browser.
Settings
KOOL Cesca Therapeutics Inc. daily Stock Chart
KOOL [NASD]
Cesca Therapeutics Inc.
Index- P/E- EPS (ttm)-1.97 Insider Own30.91% Shs Outstand22.46M Perf Week-10.20%
Market Cap6.04M Forward P/E- EPS next Y-0.10 Insider Trans0.00% Shs Float15.30M Perf Month-13.24%
Income-39.70M PEG- EPS next Q-0.08 Inst Own1.40% Short Float1.52% Perf Quarter-17.27%
Sales9.70M P/S0.62 EPS this Y-291.70% Inst Trans-0.32% Short Ratio1.45 Perf Half Y-29.22%
Book/sh0.34 P/B0.79 EPS next Y50.00% ROA-144.90% Target Price1.00 Perf Year-83.60%
Cash/sh0.11 P/C2.52 EPS next 5Y- ROE-239.70% 52W Range0.21 - 1.68 Perf YTD0.77%
Dividend- P/FCF- EPS past 5Y21.30% ROI-404.30% 52W High-84.62% Beta0.89
Dividend %- Quick Ratio0.60 Sales past 5Y-9.60% Gross Margin22.70% 52W Low23.05% ATR0.02
Employees95 Current Ratio1.40 Sales Q/Q-6.90% Oper. Margin- RSI (14)30.63 Volatility9.60% 7.82%
OptionableNo Debt/Eq0.14 EPS Q/Q-120.80% Profit Margin- Rel Volume2.80 Prev Close0.27
ShortableYes LT Debt/Eq0.14 EarningsMar 25 AMC Payout- Avg Volume160.47K Price0.26
Recom- SMA20-10.62% SMA50-20.01% SMA200-24.41% Volume320,333 Change-3.92%
May-23-18Initiated H.C. Wainwright Buy
Dec-22-15Downgrade Maxim Group Buy → Hold
Nov-17-15Reiterated Maxim Group Buy $7 → $1
Sep-21-15Upgrade H.C. Wainwright Neutral → Buy $2
May-15-15Downgrade H.C. Wainwright Buy → Neutral
Jun-26-14Initiated H.C. Wainwright Buy $5
Apr-24-14Initiated Maxim Group Buy $7
Apr-17-19 08:00AM  ThermoGenesis Releases its Enhanced X-MINI® CD3 Selection Kit for the Research Market PR Newswire
Apr-10-19 08:00AM  ThermoGenesis AXP® II and PXP® Systems Now Registered and Available in Thailand PR Newswire
Mar-25-19 04:05PM  Cesca Therapeutics Announces Fiscal 2018 Year End Financial Results And Provides Corporate Update PR Newswire
Mar-20-19 08:00AM  Cesca Therapeutics To Announce Financial Results For The Fourth Quarter Ended December 31, 2018 and Host Conference Call On March 25 PR Newswire
Feb-25-19 08:00AM  ThermoGenesis Receives Health Canada Approval of its PXP System for Automated Processing of Bone Marrow Cells PR Newswire
Feb-11-19 08:30AM  ThermoGenesis Corp X-Series Control Module and Docking Stations Cleared for Labelling by TÜV Rheinland with the cTUVus Electrical Safety Mark PR Newswire
Feb-06-19 08:30AM  Cesca Therapeutics to Present at the BIO CEO & Investor Conference PR Newswire
Feb-01-19 08:30AM  ThermoGenesis Corp Signs Strategic Supply Agreement with Orthohealing Center Management to Provide it's PXP® Point-of-Care System to Orthohealing Method Physician Members PR Newswire
Jan-21-19 08:30AM  ThermoGenesis Corp® Completes Construction and Qualification of In-House Clean Room for Assembly of All X-Series Cell Processing Disposables PR Newswire
Jan-04-19 08:30AM  Cesca Therapeutics Acquires Remaining Ownership Stake in ThermoGenesis and Forms New ThermoGenesis Subsidiary, CARTXpress Bio, Inc., to Focus on its CAR-TXpress Cellular Processing Platform PR Newswire +13.97%
Nov-20-18 09:05AM  4 Healthcare Stocks You Should Get To Know Before 2019 ACCESSWIRE -18.48%
Nov-19-18 09:56AM  Cesca Therapeutics Receives 510(k) Clearance to Market Its AXP® II AutoXpress® Platform for Clinical Cord Blood Banking PR Newswire +51.32%
Nov-14-18 04:05PM  Cesca Therapeutics Announces Third Quarter 2018 Financial Results And Provides Corporate Update PR Newswire +5.08%
Nov-13-18 08:30AM  Cesca Therapeutics Submits Device Master File (MAF) with the FDA for the X-LAB® Automated Cell Processing Devices PR Newswire +8.46%
Nov-07-18 08:30AM  Cesca Therapeutics To Announce Financial Results For The Third Quarter Ended September 30, 2018 And Host Conference Call On November 14 PR Newswire
Nov-06-18 10:30AM  Will Cesca Therapeutics (KOOL) Report Negative Earnings Next Week? What You Should Know Zacks
Nov-02-18 06:45PM  Cesca Therapeutics (KOOL) Dips More Than Broader Markets: What You Should Know Zacks
Oct-18-18 05:45PM  Cesca Therapeutics (KOOL) Stock Moves -0.73%: What You Should Know Zacks
Oct-16-18 05:27PM  Cesca Therapeutics lays off three executives to cut costs American City Business Journals +6.05%
08:30AM  Cesca Therapeutics Announces Cost Reduction Measures Aimed at Achieving Cash Flow Positive Position in 2019 PR Newswire
Sep-13-18 08:30AM  Cesca Therapeutics' Chief Executive Officer, Chris Xu, To Be The Keynote Speaker At The Cell Therapy World Asia 2018 Conference On September 20, 2018 PR Newswire +9.88%
Sep-05-18 08:30AM  Cesca Therapeutics Provides Commercialization Update For Its X-Series Product Line PR Newswire -9.04%
Aug-30-18 08:30AM  Cesca Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment Conference GlobeNewswire +8.09%
Aug-29-18 08:30AM  Cesca Therapeutics Announces Poster Presentation at the 4th Annual CAR-TCR Summit GlobeNewswire +21.32%
Aug-15-18 08:48AM  The Daily Biotech Pulse: Vertex Awaits FDA Verdict, Strongbridge Falls On Offering, ReShape's Woes Continue Benzinga
Aug-14-18 08:23AM  The Daily Biotech Pulse: Cesca, Acer Therapeutics Rally On Earnings, Aridis Makes Its Nasdaq Debut Benzinga -16.18%
Aug-13-18 04:05PM  Cesca Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
02:30PM  Cesca Therapeutics Inc. to Host Earnings Call ACCESSWIRE
Aug-06-18 08:30AM  Cesca Therapeutics to Announce Financial Results for the Second Quarter Ended June 30, 2018 and Host Conference Call on August 13 GlobeNewswire
Jul-16-18 08:30AM  Cesca Therapeutics Announces the Launch of its PXP System for Automated Processing of Bone Marrow Cells GlobeNewswire
Jun-22-18 07:18AM  Free Research Reports on Boston Scientific and Three More Medical Equipment Stocks ACCESSWIRE -6.58%
Jun-06-18 08:30AM  Cesca Therapeutics Announces Exhibition at The Orthobiologic Institutes 9th Annual PRP & Regenerative Medicine Symposium GlobeNewswire
Jun-04-18 05:56PM  Rancho Cordova-based Cesca Therapeutics cutting about 20 jobs American City Business Journals
08:30AM  Cesca Therapeutics Announces Reduction in Operating Expenses GlobeNewswire
May-31-18 02:02PM  Cesca Therapeutics Incs (NASDAQ:KOOL) Profit Outlook Simply Wall St.
May-23-18 02:47PM  Cesca Therapeutics Snags Bullish HC Wainwright Initiation On CAR-T Opportunity Benzinga
08:30AM  Cesca Therapeutics Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process in Cell & Gene Therapy GlobeNewswire
May-18-18 11:12AM  Cesca Announces Closing of $5.5 Million Public Offering GlobeNewswire
May-17-18 08:10AM  Todays Research Reports on Stocks to Watch: Abaxis, Inc. and Cesca Therapeutics ACCESSWIRE
May-16-18 12:00PM  Cesca Prices $5.5 Million Public Offering GlobeNewswire -30.92%
08:10AM  Benzinga's Daily Biotech Pulse: Verastem Uprooted On Stock Offering, Titan Pharma Earnings Benzinga
May-14-18 04:05PM  Cesca Therapeutics Announces First Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
12:15PM  Cesca Therapeutics Inc. to Host Earnings Call ACCESSWIRE
May-09-18 08:30AM  Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2018 and Host Conference Call on May 14 GlobeNewswire
May-04-18 05:00PM  Cesca Therapeutics Inc. Presents New Data on its Proprietary X-Series Cellular Processing Systems GlobeNewswire
Apr-25-18 08:30AM  Cesca Therapeutics Inc. to Exhibit at Several Upcoming Cell Therapy Conferences GlobeNewswire -7.14%
Apr-24-18 08:30AM  Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series Products That Provide Automated, Closed System Cellular Processing GlobeNewswire
Apr-18-18 07:30AM  Blog Exposure - AcelRx Pharma Completes the Human Factors Study for DSUVIA ACCESSWIRE +14.10%
Apr-17-18 02:21PM  Has Cesca Therapeutics Inc (NASDAQ:KOOL) Improved Earnings Growth In Recent Times? Simply Wall St.
08:30AM  Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series Products That Provide Automated, Closed System Cellular Processing GlobeNewswire
Apr-03-18 08:30AM  Cesca Therapeutics Inc. Announces Release of X-Mini Cell Selection Kit for the CAR-T Research Market GlobeNewswire
Mar-28-18 07:00AM  Cesca Therapeutics Inc. Announces Two Abstracts Accepted for Poster Presentation at the International Society for Cellular Therapy (ISCT) 2018 Annual Meeting GlobeNewswire
Mar-26-18 05:53PM  Cesca raising $1.4 million in direct offering of stock American City Business Journals -16.79%
09:00AM  Cesca Therapeutics Announces Registered Direct Offering GlobeNewswire
Mar-22-18 04:05PM  Cesca Therapeutics Announces Financial Results for the Transition Period July 1, 2017 to December 31, 2017, and Provides Corporate Update GlobeNewswire
12:30PM  Cesca Therapeutics Inc. to Host Earnings Call ACCESSWIRE
Mar-19-18 07:00AM  Cesca Therapeutics Expands CAR-TXpress Intellectual Property Portfolio with Filing of New Patent Covering Cell Activation & Transduction GlobeNewswire
Mar-15-18 07:00AM  Cesca Therapeutics to Announce Financial Results for the Transition Period From July 1, 2017 to December 31, 2017 on March 22 GlobeNewswire -7.41%
Mar-14-18 07:00AM  Cescas Device Subsidiary, ThermoGenesis, Expands into CAR-T Related Contract Development and Manufacturing (CDMO) Services GlobeNewswire
Mar-06-18 07:00AM  Cesca Therapeutics Inc. to Present at BIO-Europe Spring® 2018 GlobeNewswire
Feb-28-18 07:00AM  Cesca Therapeutics Inc. to Present at the 8th Spring Meeting of the International Society for BioProcess Technology (ISBiotech) GlobeNewswire
Feb-26-18 07:00AM  Cesca Therapeutics Inc. Announces Commercial Launch of AXP® II System for Advanced Cord Blood Processing GlobeNewswire
Feb-09-18 11:42AM  Cesca Therapeutics Inc (NASDAQ:KOOL) And The Healthcare Industry Prospect For 2018 Simply Wall St.
Feb-05-18 07:00AM  Cesca Therapeutics Inc. to Present at the BIO CEO & Investor Conference on Monday, February 12, 2018 GlobeNewswire
Jan-08-18 03:22PM  Why Cesca Therapeutics Incs (NASDAQ:KOOL) Investor Composition Impacts Your Returns Simply Wall St.
Jan-02-18 07:00AM  Cesca Therapeutics Inc. to Present at Biotech Showcase on Tuesday, January 9, 2018 GlobeNewswire
Jan-01-18 12:45PM  Where Cesca Therapeutics Inc (NASDAQ:KOOL) Stands In Terms Of Earnings Growth Against Its Industry Simply Wall St.
Dec-27-17 11:26AM  ETFs with exposure to Cesca Therapeutics, Inc. : December 27, 2017 Capital Cube
Dec-26-17 08:56AM  Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: Q1, 2018 By the Numbers : December 26, 2017 Capital Cube
Dec-07-17 01:03PM  How Financially Strong Is Cesca Therapeutics Inc (KOOL)? Simply Wall St.
Dec-01-17 10:40AM  ETFs with exposure to Cesca Therapeutics, Inc. : December 1, 2017 Capital Cube
Nov-30-17 07:30AM  Cesca Therapeutics Inc. to Participate in the LD Micro 10th Annual Main Event on Thursday, December 7, 2017 GlobeNewswire
Nov-29-17 06:10PM  Cesca Therapeutics aims to raise nearly $3 million with share offering American City Business Journals -8.28%
09:07AM  Cesca Therapeutics Inc. Announces Pricing of Public Offering of up to 900,000 shares of Common Stock GlobeNewswire
Nov-28-17 05:20PM  Cesca Therapeutics Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire -10.29%
07:30AM  Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent GlobeNewswire
Nov-22-17 07:30AM  Cesca Therapeutics Appoints Healthcare Investment Banking Veteran Joe E. Balagot as Senior Vice President of Corporate Development GlobeNewswire -6.54%
Nov-14-17 04:05PM  Cesca Therapeutics Announces Financial Results for the Three Months Ended September 30, 2017 and Provides Corporate Update GlobeNewswire
10:00AM  Cesca Therapeutics Inc. to Host Earnings Call ACCESSWIRE
07:30AM  Cesca Therapeutics to Present at the Advanced Cell Therapy Shanghai Summit 2017 GlobeNewswire
Nov-07-17 07:00AM  Cesca Therapeutics to Announce Financial Results for the Three Months Ended September 30, 2017 and Host Conference Call on November 14th GlobeNewswire
Nov-06-17 11:55AM  ETFs with exposure to Cesca Therapeutics, Inc. : November 6, 2017 Capital Cube
Oct-27-17 11:02AM  ETFs with exposure to Cesca Therapeutics, Inc. : October 27, 2017 Capital Cube
Oct-17-17 09:49AM  ETFs with exposure to Cesca Therapeutics, Inc. : October 17, 2017 Capital Cube
Oct-09-17 07:20AM  Corporate News Blog - German Court Stays Infringement Proceedings Against Fisher & Paykel In ResMed Patent Infringement Case ACCESSWIRE -5.52%
Oct-06-17 10:56AM  ETFs with exposure to Cesca Therapeutics, Inc. : October 6, 2017 Capital Cube
Oct-04-17 09:15AM  Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: Q4, 2017 By the Numbers : October 4, 2017 Capital Cube -8.32%
08:20AM  Today's Research Reports on Stocks to Watch: Celsion Corporation and Cesca Therapeutics ACCESSWIRE
Oct-03-17 07:00AM  Cesca Receives Notice of Allowance for U.S. Patent Application Covering a Novel Method of Cell Separation GlobeNewswire +33.61%
Sep-27-17 07:00AM  Cesca Therapeutics to Present at the 2017 Cell & Gene Meeting on the Mesa GlobeNewswire
Sep-26-17 10:55AM  ETFs with exposure to Cesca Therapeutics, Inc. : September 26, 2017 Capital Cube
Sep-25-17 01:23PM  Cesca Therapeutics to Present at Cell & Gene Therapy Bioprocessing & Commercialization 2017 GlobeNewswire
09:42AM  Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: 2017 By the Numbers : September 25, 2017 Capital Cube
Sep-22-17 07:48AM  Cesca Therapeutics Inc (KOOL) Files 10-K for the Fiscal Year Ended on June 30, 2017 GuruFocus.com
Sep-19-17 04:05PM  Cesca Therapeutics Announces Fiscal Year 2017 Financial and Operating Results and Provides Corporate Update GlobeNewswire
12:00PM  Investor Network: Cesca Therapeutics Inc. to Host Earnings Call ACCESSWIRE
Sep-12-17 07:00AM  Cesca Therapeutics to Announce Fiscal Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on September 19, 2017 GlobeNewswire
Sep-05-17 07:00AM  CESCA Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference GlobeNewswire
Aug-31-17 07:00AM  Cesca Therapeutics to Participate in the CAR-TCR Summit 2017 GlobeNewswire
Aug-29-17 03:35PM  Distribution deal could help Rancho Cordova's Cesca expand into growing Asian markets American City Business Journals
Cesca Therapeutics Inc. develops, commercializes, and markets a range of automated technologies and products for cell-based therapeutics in the United States, China, rest of Asia, Europe, and internationally. The company develops automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. It offers AutoXpress System, a proprietary automated device and companion sterile disposable for concentrating hematopoietic stem cells from cord blood; Point-of-CareXpress System, a proprietary automated device and companion sterile disposable for the isolation and concentration of hematopoietic stem cells from bone marrow; CAR-TXpress System, a suite of multi-component automated system that allows the automated manufacturing, expansion, and storage of cellular therapies for immuno-oncology; BioArchive System, an automated cryogenic device for single-cassette based cryo-storage of biological license applications products; and manual bag sets for use in the processing and cryogenic storage of cord blood. The company is also developing autologous stem cell-based therapies that address medical needs for applications in the vascular, cardiology, and orthopedic markets. In addition, it provides cell manufacturing and banking services. The company was formerly known as ThermoGenesis Corp. and changed its name to Cesca Therapeutics Inc. in February 2014. Cesca Therapeutics Inc. was founded in 1986 and is headquartered in Rancho Cordova, California. Cesca Therapeutics Inc. is a subsidiary of Boyalife (Hong Kong) Limited.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JOSEPH THOMISDirectorAug 28Buy0.1835,0006,30035,000Aug 30 05:32 PM